Zobrazeno 1 - 10
of 99
pro vyhledávání: '"M A MASCHAN"'
Autor:
E. V. Volchkov, A. A. Khozyainova, M. Kh. Gurzhikhanova, I. V. Larionova, V. E. Matveev, D. A. Evseev, A. K. Ignatova, M. E. Menyailo, D. A. Venyov, R. S. Vorobev, A. A. Semchenkova, Yu. V. Olshanskaya, E. V. Denisov, M. A. Maschan
Publikováno v:
npj Systems Biology and Applications, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Juvenile myelomonocytic leukemia (JMML) is a rare myeloproliferative disease of early childhood that develops due to mutations in the genes of the RAS-signaling pathway. Next-generation high throughput sequencing (NGS) enables identification
Externí odkaz:
https://doaj.org/article/8653776d94114edea55191f30c4446f9
Autor:
V. M. Ukrainskaya, O. E. Musatova, D. V. Volkov, D. S. Osipova, D. S. Pershin, A. M. Moysenovich, E. G. Evtushenko, E. A. Kulakovskaya, E. G. Maksimov, H. Zhang, Y. P. Rubtsov, M. A. Maschan, A. V. Stepanov, A. G. Gabibov
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Tumor-derived extracellular vesicles (EVs) are active contributors in metastasis and immunosuppression in tumor microenvironment. At least some of the EVs carry tumor surface molecules such as tumor-associated antigens (TAAs) and/or checkpoi
Externí odkaz:
https://doaj.org/article/2cb173f3f63b4d86a4068a2d2e7d646a
Autor:
M. A. Maschan, N. V. Myakova
Publikováno v:
Онкогематология, Vol 0, Iss 1-2, Pp 50-63 (2022)
Externí odkaz:
https://doaj.org/article/9b8fce61f19a4307a7466339a8100122
Autor:
E. V. Samochatova, D. D. Baidildina, M. A. Maschan, N. N. Savva, O. P. Khlebnikova, A. V. Shamardina, Yu. E. Mareiko, G. A. Tsaur, T. O. Riger, M. M. Shneider, Yu. V. Rumyantseva, T. V. Nasedkina, T. V. Savitskaya, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 8-17 (2022)
The use of all-trans retinoic acid (ATRA) drastically improved the results of therapy for acute promyelocytic leukeimia (APL). The high efficiency of the Russian protocol APL-93—98 applied to 62 children and adolescents with APL (event-free and ove
Externí odkaz:
https://doaj.org/article/a1999c503e6849b689ddc0507d049b22
Autor:
G. G. Solopova, D. D. Baidildina, L. I. Zharikova, I. I. Kalinina, U. N. Petrova, Ye. V. Suntsova, O. V. Goronkova, L. A. Hachatryan, V. V. Sinitsina, G. A. Novichkova, A. A. Maschan, M. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 8-15 (2022)
Standard therapy of high risk patients with Langerhans cell histiocytosis (LCH) is associated with essential risk of therapy failure. In the present study results of 2-clorodeoxyadenosine usage as alternative therapy in this group of patients are ana
Externí odkaz:
https://doaj.org/article/aff35ebb6ec14d3cbe54f0f6a680cf5f
Autor:
N. P. Kirsanova, O. V. Aleinikova, A. M. Kustanovich, T. V. Savitskay, R. I. Yutskevich, E. V. Volochnik, L. V. Baidun, Yu. E. Mareiko, Yu. S. Strongin, N. V. Minakovskay, N. V. Migal, I. V. Proleskovskay, I. V. Emelyanova, O. V. Karas, A. G. Drekov, M. M. Maschan, D. V. Litvinov, N. V. Myakova, E. V. Skorobogatova, D. D. Baidildina, I. I. Kalinina, G. G. Solopova, E. V. Suntsova, U. N. Petrova, L. A. Hachatryan, M. M. Scheider, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 5-13 (2022)
Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with primary acute myeloid leukemia (AML) in Russia and Belarus are presented. 105 children at the age from 2 weeks till 18 years (a median age — 10.8 years) are inc
Externí odkaz:
https://doaj.org/article/b5947a60a3844a338c3bdb12bb102b9d
Autor:
L. A. Khachatrian, M. A. Maschan, Ye. V. Samochatova, M. M. Schneider, D. D. Baidildina, G. G. Solopova, Ye. V. Suntzova, L. I. Zjarikova, U. N. Petrova, V. V. Sinitsina, G. A. Novichkova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 1-2, Pp 34-38 (2022)
Prognosis of patients with juvenile myelomonocytic leukemia not undergoing allogeneic hematopoietic cells transplantation (SCT) is dismal and not affected by any cytotoxic chemotherapy. Differentiating therapy is an attractive approach in JMML, due t
Externí odkaz:
https://doaj.org/article/fd2660cb6eaf48aa8f9d1014cd95ecab
Autor:
N. Yu. Shipovskaya, E. V. Samochatova, O. B. Polushkina, M. A. Maschan, I. I. Kalinina, A. N. Gracianskay, M. N. Kostileva, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 2, Pp 70-74 (2022)
Introduction of biosimilars in clinical practice results in substantial reduction of direct medical costs. However, limited data concerning safety and tolerance of biosimilars exist, especially in children. We conducted double blind randomized trial
Externí odkaz:
https://doaj.org/article/db4beeeafdcc46779093ed79607dbe40
Autor:
A. K. Ignatova, I. I. Kalinina, D. A. Venev, T. Yu. Salimova, D. A. Evseev, M. N. Sadovskaya, O. V. Goronkova, V. E. Matveev, U. N. Petrova, K. S. Antonova, D. D. Baydildina, M. E. Dubrovnaya, T. V. Konyukhova, Yu. V. Olshanskaya, D. S. Abramov, M. A. Maschan, G. A. Novichkova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 16, Iss 1, Pp 10-22 (2021)
Background. Extramedullary infiltration (EI) is relatively common in children with acute myeloid leukemia (AML) (up to 20-25 %). However, its clinical and prognostic significance remains poorly understood.Objective: to describe clinical features and
Externí odkaz:
https://doaj.org/article/14fb36d0acc24523992dfb11fa1cebf2
Autor:
N. P. Leonov, V. V. Schukin, G. A. Novichkova, M. A. Maschan, F. I. Ataullakhanov, S. S. Yashin, A. M. Zeynalov, Е. A. Spiridonova
Publikováno v:
Общая реаниматология, Vol 16, Iss 3, Pp 54-75 (2020)
Coagulopathy always accompanies blood loss, and its transformation into disseminated intravascular coagulation syndrome (DIC) is associated with increased morbidity and mortality.Objective: to characterize the features of the development and course o
Externí odkaz:
https://doaj.org/article/7fc1881ea80344e2b7280a2b11eee2f7